(S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline
98%
blur_circular Chemical Specifications
description Product Description
This compound is primarily utilized in pharmaceutical research and development, particularly in the study of central nervous system (CNS) disorders. Its structural features make it a potential candidate for targeting specific receptors or enzymes involved in neurological pathways. Researchers explore its efficacy in modulating neurotransmitter activity, which could lead to the development of novel treatments for conditions such as depression, anxiety, or neurodegenerative diseases. Additionally, its unique chemical structure allows for further derivatization, enabling the creation of analogs with optimized pharmacological properties. It is also investigated for its potential role in pain management and as a tool compound in preclinical studies to understand disease mechanisms.
format_list_bulleted Product Specification
| Test Parameter | Specification |
|---|---|
| Appearance | Light Yellow to Yellow Solid |
| Purity (%) | 97.5-100% |
| Infrared Spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
shopping_cart Available Sizes & Pricing
Cart
No products